MedPath

Effect of magnesium supplementation on improvement of patients with diabetic nephropathy

Phase 2
Conditions
Diabetes.
Diabetic nephropathy
Registration Number
IRCT201404271485N12
Lead Sponsor
Isfahan University of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

More than 18 years old
Diabetic nephropathy
Blood glucose more than 126 milligram per decilite
Proteinuria between 30 to 300 milligram per deciliter (micro-albuminuria)
Glomerular Filtration Rate more than 90 milliliter per minute
Not having hypothyroidism and hyperthyroidism; Not having any urine duct infection; Not having any feverish infection; Not using cigarette or other drugs; Not having liver disease; Not having cancer; Not having any inflammatory disease
Not losing weight more than 4 kilogram during last 3 months
Not using any magnesium-rich supplement

Exclusion Criteria

Changing medicine doses
failure to adherence (using less than 75 percent of medicines)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Albumin to creatinine ratio (UACR). Timepoint: Baseline, week 12. Method of measurement: Commercial kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath